Veru Class Action Lawsuit VERU | Deadline February 6, 2023

According to the Veru lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:

1) the Company had withheld material adverse facts about the data from the sabizabulin Phase 3 trial and the Company’s interactions with the United States Food and Drug Administration;

2) defendants misled Veru’s shareholders to believe that the data from the sabizabulin Phase 3 trial was sufficient to support Emergency Use Authorization (“EUA”) and even the submission of a New Drug Application without any further studies; and

3) the Company’s filings concealed the true risks faced by Veru in gaining approval for its EUA request.

To learn more about the VERU lawsuit, contact us today.

If you suffered a loss in Veru you have until February 6, 2023, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.